DEFA5 and metabolic dysfunction-associated steatotic liver disease: In MASLD and obesity, changes in defensin levels (such as α-defensins 5 and 6) may lead to an altered gut microbiota composition that promotes dysbiosis, systemic inflammation, and disruption of gut barrier integrity.